Benoit Larrant | BiotechTV

top of page

TheraSonic has developed a robotic ultrasound device that is designed to help get medicines past the blood-brain-barrier. It is part of Paris Saclay Cancer Cluster's BOOST accelerator program

Co-Founder and CEO Benoit Larrant describes the company's technology and the help it has been receiving from the BOOST program and the broader biotech ecosystem in Paris.

Jun 4

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

Learn more

bottom of page

TheraSonic has developed a robotic ultrasound device that is designed to help get medicines past the blood-brain-barrier. It is part of Paris Saclay Cancer Cluster's BOOST accelerator program

Follow BiotechTV

Sponsors

Sponsor Spotlight